Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

89,703 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells.
Maxwell T, Lee KS, Kim S, Nam KS. Maxwell T, et al. Int J Oncol. 2018 Apr;52(4):1339-1349. doi: 10.3892/ijo.2018.4271. Epub 2018 Feb 9. Int J Oncol. 2018. PMID: 29436614
Determination of the optimal time for tamoxifen treatment in combination with radiotherapy.
Jang H, Baek J, Nam KS, Kim S. Jang H, et al. Int J Oncol. 2016 Nov;49(5):2147-2154. doi: 10.3892/ijo.2016.3687. Epub 2016 Sep 9. Int J Oncol. 2016. PMID: 27633191
Generally, clinician's opinion and experience are major determinants in scheduling concurrent or sequential tamoxifen and radiotherapy. ...
Generally, clinician's opinion and experience are major determinants in scheduling concurrent or sequential tamoxifen and radiotherap …
89,703 results
Jump to page
Feedback